Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice
- 26 June 2004
- journal article
- Published by Elsevier BV in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 348 (1-2), 63-68
- https://doi.org/10.1016/j.cccn.2004.04.029
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Pharmacokinetic study of ellagic acid in rat after oral administration of pomegranate leaf extractJournal of Chromatography B, 2003
- Intestinal epithelial cell accumulation of the cancer preventive polyphenol ellagic acid—extensive binding to protein and DNABiochemical Pharmacology, 2003
- Repeated Oral Administration of High Doses of the Pomegranate Ellagitannin Punicalagin to Rats for 37 Days Is Not ToxicJournal of Agricultural and Food Chemistry, 2003
- Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juiceEuropean Journal of Nutrition, 2003
- Ellagitannins - nature, occurrence and dietary burdenJournal of the Science of Food and Agriculture, 2000
- Antimutagenicity of ellagic acid towards the food mutagen IQ: Investigation into possible mechanisms of actionFood and Chemical Toxicology, 1992
- Biodistribution of ellagic acid and dose‐related inhibition of lung tumorigenesis in A/J miceNutrition and Cancer, 1992
- Disposition of the plant phenol ellagic acid in the mouse following oral administration by gavageXenobiotica, 1988
- Disposition of the naturally occurring antimutagenic plant phenol, ellagic acid, and its synthetic derivatives, 3-O-decylellagic acid and 3, 3'-di-O-methylellagic acid in miceCarcinogenesis: Integrative Cancer Research, 1986
- The metabolism of ellagic acid in the ratXenobiotica, 1980